Drug Companies Should Answer the Call to Lower Weight Loss Drug Prices
Pharmacy benefit managers deliver on their mission every day to expand access to prescription drugs, saving Americans on average $1,040 per person annually. Last month, three leading pharmacy benefit companies pledged to Sen. Bernie Sanders, the chairman of the Senate Committee on Health, Education, Labor and Pensions — ahead of a recent congressional hearing where major drug manufacturer Novo Nordisk testified on how the company chooses to price popular GLP-1 drugs — that they are committed to facilitating access to these drugs, should Novo Nordisk (and other GLP-1 drug manufacturers) decide to lower the price of certain GLP-1s to $100 or less per patient per month for health plan sponsors.